Business · 13/07/2020
FDA Announces Final Guidance on Cancer Clinical Trial Eligibility Criteria for Pediatric Patients
The FDA has released a final guidance document outlining the eligibility criteria for pediatric patients to participate in cancer clinical trials, providing recommendations for industry and institutional review boards.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →